[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100656187":3},{"organization":4,"outcomesModule":7,"designInfo":13,"detailedDescription":15,"studyPopulation":16,"armGroups":17,"interventions":11,"overallOfficials":11,"centralContacts":20,"locations":26,"responsibleParty":42,"collaborators":11,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":11,"eligibilityCriteria":51,"healthyVolunteers":48,"sex":52,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":11,"studyType":58,"phases":11,"briefSummary":59,"conditions":60,"keywords":63,"overallStatus":29,"whyStopped":11,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Sohag University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":11,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Prevalence of polyendocrine metabolic ovarian syndrome (PMOS) among patients diagnosed with acne vulgaris in Sohag university hospital",null,"Over 1 year",{"allocation":11,"interventionModel":11,"interventionModelDescription":11,"primaryPurpose":11,"observationalModel":6,"timePerspective":14,"maskingInfo":11},"CROSS_SECTIONAL","A cross-sectional observational study designed to determine the prevalence of polycystic ovary syndrome (PCOS) among patients diagnosed with acne vulgaris attending Sohag University Hospital.","Female patients diagnosed with acne vulgaris",[18],{"label":19,"type":11,"description":11,"interventionNames":11},"Patients diagnosed with acne vulgaris",[21],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},"Omar Shazly Saleh, Resident","CONTACT","+201004861933","oshazly399@gmail.com",[27],{"facility":28,"status":29,"city":30,"state":11,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Sohag university hospital","RECRUITING","Sohag","82511","Egypt","EG",{"type":35,"coordinates":36},"Point",[37,38],31.69478,26.55695,{"lat":38,"lon":37},[41],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Omar Shazly Saleh","Dermatology, Venereology and Andrology resident","100656187","prevalence-of-polyendocrine-metabolic-ovarian-syndrome-in-patients-diagnosed-with-acne-vulgaris-in-sohag-university-hospital-100656187",false,"NCT07822360","Prevalence of Polyendocrine Metabolic Ovarian Syndrome in Patients Diagnosed With Acne Vulgaris in Sohag University Hospital","Inclusion Criteria:\n\n* Female patients at childbearing age ( 15 - 49 years) (World Health, 2024).\n* Patients clinically diagnosed with acne vulgaris.\n\n  • Clinical diagnosis of Acne vulgaris:\n\n  o Presence of comedones (open\u002Fblack and closed\u002Fwhite), inflammatory lesions (papules, pustules, or nodules), with or without post-acne changes such as hyperpigmentation or scarring (Oge et al., 2019).\n* Patients diagnosed with polyendocrine metabolic ovarian syndrome (PMOS) according to the 2023 International Evidence-based Guideline for PCOS diagnosis.\n* Diagnostic criteria for PMOS diagnosis in adults : (Forslund et al., 2024).\n\n  * Diagnosis of PMOS will be based on the presence of at least two of the following three criteria after exclusion of other etiologies:\n\n    1\\. Ovulatory dysfunction:\n    * Irregular menstrual cycles or oligo\u002Fanovulation. 2. Clinical and\u002For biochemical hyperandrogenism:\n    * Clinical signs such as hirsutism and\u002For acne, or biochemical evidence of elevated androgen levels.\n\n      3\\. Polycystic ovarian morphology (PCOM):\n    * Polycystic ovaries detected by pelvic ultrasound, or elevated anti-Müllerian hormone (AMH) level in adults as an alternative to ultrasound.\n  * Most women with PMOS have a combination of hyperandrogenism and irregular cycles, and in these cases there is no need to assess PCOM. In adolescents, both ovulatory dysfunction and hyperandrogenism are mandatory (Forslund et al., 2024).\n* Patients willing to participate and provide informed consent.\n\nExclusion Criteria:\n\n* Pregnant women.\n* Lactating mothers\n* Women diagnosed with other acneiform lesions\n* Women on certain drug treatments like oral contraceptive pills, ovarian stimulating drugs and oral hypoglycemic agents like metformin.\n* Patients with incomplete clinical data or who refuse to participate in the study.","FEMALE","15 Years","49 Years",{"count":56,"type":57},90,"ESTIMATED","OBSERVATIONAL","The aim of this study is to determine the prevalence of polyendocrine metabolic ovarian syndrome (PMOS) among female patients diagnosed with acne vulgaris in Sohag university hospital",[61,62],"Polyendocrine Metabolic Ovarian Syndrome","Acne Vulgaris",[64,65,66],"Polyendocrine metabolic ovarian syndrome","Acne vulgaris","PMOS","2026-09-10",{"date":69,"type":70},"2026-09-16","ACTUAL",{"date":72,"type":70},"2026-08-09",{"date":74,"type":57},"2027-05",{"name":5,"class":6},1]